Osaic Holdings’s Petros Pharmaceuticals PTPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8
| Closed | -$14 | – | 7855 |
|
|
2025
Q1 | $14 | Hold |
8
| – | – | ﹤0.01% | 7364 |
|
|
2024
Q4 | $78 | Hold |
8
| – | – | ﹤0.01% | 7266 |
|
|
2024
Q3 | $72 | Buy |
+8
| New | +$75 | ﹤0.01% | 7271 |
|
|
2024
Q2 | – | Sell |
-1
| Closed | -$21 | – | 7573 |
|
|
2024
Q1 | $21 | Hold |
1
| – | – | ﹤0.01% | 7120 |
|
|
2023
Q4 | $20 | Hold |
1
| – | – | ﹤0.01% | 7205 |
|
|
2023
Q3 | $24 | Hold |
1
| – | – | ﹤0.01% | 7309 |
|
|
2023
Q2 | $28 | Hold |
1
| – | – | ﹤0.01% | 7357 |
|
|
2023
Q1 | $20 | Sell |
1
-4
| -80% | -$228 | ﹤0.01% | 7424 |
|
|
2022
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 7380 |
|
|
2022
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 7043 |
|
|
2022
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 7133 |
|
|
2022
Q1 | $2K | Hold |
5
| – | – | ﹤0.01% | 6905 |
|
|
2021
Q4 | $3K | Sell |
5
-2
| -29% | -$1.17K | ﹤0.01% | 6896 |
|
|
2021
Q3 | $4K | Sell |
7
-3
| -30% | -$1.95K | ﹤0.01% | 6646 |
|
|
2021
Q2 | $8K | Buy |
10
+2
| +25% | +$1.6K | ﹤0.01% | 6204 |
|
|
2021
Q1 | $7K | Sell |
8
-2
| -20% | -$1.88K | ﹤0.01% | 6039 |
|
|
2020
Q4 | $11K | Buy |
+10
| New | +$9.41K | ﹤0.01% | 5481 |
|
Osaic Holdings's PTPI Position: Q2 2025 in Review
Osaic Holdings sold out of Petros Pharmaceuticals (PTPI) in Q2 2025, closing a stake of 8 shares — an estimated $14 sold.
Osaic Holdings first reported a position in PTPI in Q4 2020 and held it in 17 quarters. The position peaked at $11K in Q4 2020. 0 funds tracked by Wall St. Rank hold PTPI as of Q2 2025.
- Osaic Holdings reported no remaining Petros Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Osaic Holdings sold 8 Petros Pharmaceuticals shares in Q2 2025, an estimated $14.
- Osaic Holdings first reported a position in Petros Pharmaceuticals in Q4 2020 and held it in 17 quarters.
- Osaic Holdings's Petros Pharmaceuticals position peaked at $11K in Q4 2020.
- 0 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2025.
Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.